UNSPSC 85513457: Supplement celiac artery with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement celiac artery with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04U147Z

UNSPSC 85513457 Supplement celiac artery with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The code describes a specific surgical procedure — vascular augmentation using autologous tissue — but the six recent state and local contract opportunities posted under this code span independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve celiac artery supplementation or the procedural intervention the code nominates. The mismatch suggests either miscoding by issuing bodies or that the code has been repurposed in state and local procurement systems to encompass broader medical services administration rather than the specific surgical intervention its name describes.

The opportunities do not support a decision to pursue this code as defined. Buyers tagging work under 85513457 are routing medical administration, staffing, and benefit management contracts through a surgical-procedure code, creating noise rather than signal for vendors seeking actual procurement of the procedure or related surgical supplies. Geographic spread across Arizona, California, Florida, and Washington and issuing bodies including city retirement offices, municipal human resources departments, county health systems, and state transportation agencies confirms activity volume, but the systematic mismatch between the code's nominal scope and actual solicitations indicates the code is not a reliable targeting vector for business development focused on vascular intervention or surgical services.